Advertisements



We are Sorry, This Page doesn't Exist


SurveyMonkey Announces Potential Pricing for IPO

SurveyMonkey expects to price more than 13 million shares for an initial public offering valued up to more than $170 million......»»

Category: blogSource: 247wallstSep 13th, 2018

Bank7 Announces Potential Pricing for IPO

Bank7 intends to price more than 3 million shares to result in an initial public offering valued up to more than $80 million......»»

Category: blogSource: 247wallstSep 10th, 2018

Eventbrite Announces Potential Pricing for IPO

Eventbrite intends to price its 10 million shares to result in an initial public offering valued up to more than $241 million......»»

Category: blogSource: 247wallstSep 7th, 2018

Mesa Air Announces Potential Pricing for IPO

Regional air carrier Mesa Air Group expects to price more than 10 million shares for an initial public offering valued up to more than $184 million......»»

Category: blogSource: 247wallstJul 30th, 2018

Sonos Announces Potential Pricing for IPO

Smart speaker maker Sonos expects to price its almost 14 million shares to result in an initial public offering valued up to more than $303 million......»»

Category: blogSource: 247wallstJul 23rd, 2018

Tilray Announces Potential Pricing for IPO

Medical cannabis pioneer Tilray expects to price about 9 million shares in an initial public offering valued up to more than $165 million......»»

Category: blogSource: 247wallstJul 17th, 2018

AFG Holdings Announces Potential Pricing for IPO

Original equipment manufacturer AFG intends to sell more than 18 million shares in an initial public offering valued up to more than $376 million......»»

Category: blogSource: 247wallstJul 9th, 2018

Forty Seven Announces Potential Pricing for IPO

Clinical-stage immuno-oncology company Forty Seven intends to price more than 6 million shares so that the entire offering is valued up to more than $123 million......»»

Category: blogSource: 247wallstJun 18th, 2018

Momenta announces presentation on potential for anti-FcRn therapeutics

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 17th, 2018

Evelo Announces Potential Pricing for IPO

Evelo Biosciences expects to price its more than 5 million shares in a range that results in an initial public offering valued up to almost $104 million......»»

Category: blogSource: 247wallstApr 30th, 2018

Unity Biotech Announces Potential Pricing for IPO

Unity Biotechnology plans to offer 5 million shares in an initial public offering valued up to more than $103 million......»»

Category: blogSource: 247wallstApr 24th, 2018

Smartsheet Announces Potential Pricing for IPO

Smartsheet intends to price more than 11 million shares in a range that results in an initial public offering valued up to more than $160 million......»»

Category: blogSource: 247wallstApr 16th, 2018

First Caribbean International Bank Announces Potential Pricing for IPO

First Caribbean International Bank expects to price its more than 9 million shares for an initial public offering valued up to $276 million......»»

Category: blogSource: 247wallstApr 11th, 2018

Surface Oncology Announces Potential Pricing for IPO

Surface Oncology intends to price 6 million shares to result in an initial public offering valued up to more than $103 million......»»

Category: blogSource: 247wallstApr 9th, 2018

Menlo Therapeutics announces results from Phase 2 trial of Serlopitant

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 8th, 2018

Melinta Therapeutics announces CHMP approval recommendation for Vabomere

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 21st, 2018

Spark Therapeutics announces CHMP approval recommendation for Luxturna

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 21st, 2018

Galectin Therapeutics announces preliminary data from Phase 1b trial of GR-MD-02

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 20th, 2018

Viking Therapeutics Has Incredible Potential

Viking Therapeutics Has Incredible Potential.....»»

Category: topSource: seekingalphaSep 19th, 2018

Menlo Therapeutics management to meet with Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 19th, 2018